Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹241 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹241 Cr
Mar2024₹280 Cr
Mar2023₹23 Cr
Mar2022₹-44 Cr
Mar2021₹-30 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹241 Cr
-13.91
Mar2024 ₹280 Cr
1,129.76
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr
Negative
Mar2021 ₹-30 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,083.7 Cr 0.6% -5.1% -25.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,090.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹226,976.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,639.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹115,216.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr -1.7% -0.1% -6.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.6%

-5.1%

-25.9%

SENSEX

-0.6%

1%

-3.7%


You may also like the below Video Courses